Remove Epilepsy Remove Medicine Remove Safety
article thumbnail

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK: Another Tory MP Urges Govt Action On Medical Cannabis

Cannabis Law Report

The MP for Hemel Hempstead Sir Mike Penning has spoken in a debate on access to medicinal cannabis on the NHS. Three years ago, he was instrumental in securing the backing of Parliament and the then Prime Minister Theresa May in making the use of medicinal cannabis legal to treat conditions such as rare forms of epilepsy in children.

article thumbnail

France seeks patients for medicinal cannabis trial

Cannabis Law Report

The two-year experiment is being overseen by the French Agency for Drug Safety (ANSM), which drew up a 13-name committee to explore the possibilities of reform in one of Europe’s largest markets in December 2018. France is searching for patients to take part in an official medical cannabis trial, but users will not be smoking the drug.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Cannabis-based medicinal products. Severe treatment-resistant epilepsy. Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. Tools and resources.

article thumbnail

Virginia, Marijuana, and How Medical Legalization May Unfold in the South

NORML

HB1445/SB1235, unfortunately, didn’t provide a framework for cultivating or distributing medicines, so patients had to get their cannabis from another state (a no-no under the US Department of Justice’s now-rescinded guidelines ). As in, no to anyone who wasn’t an epilepsy patient.]. They were all fine with that?

Marijuana 215
article thumbnail

Mother & Son Walking Across The UK To Raise Awareness Of Lack Of Medical Cannabis Access

Cannabis Law Report

Forbes report… A young boy and his single mother are in the midst of a 1,000-mile walk across the United Kingdom, a journey they are making to raise awareness and funds to provide medicinal cannabis to chronically ill patients. The walk is also serving as a call to action for the U.K. The Boy Who Changed The Law.

Access 104